Core Viewpoint - The stock of Chongqing Zhongyao Holdings has shown a positive trend with a 3.55% increase year-to-date and a 2.03% rise on November 7, 2023, indicating strong market interest and performance in the pharmaceutical distribution sector [1][2]. Financial Performance - For the period from January to September 2025, Zhongyao Holdings achieved a revenue of 62.211 billion yuan, reflecting a year-on-year growth of 4.22% [2]. - The net profit attributable to shareholders for the same period was 384 million yuan, marking a significant increase of 31.41% compared to the previous year [2]. Shareholder Information - As of September 30, 2025, the number of shareholders for Zhongyao Holdings was 42,000, a decrease of 4.05% from the previous period [2]. - The average number of circulating shares per shareholder increased by 4.22% to 41,112 shares [2]. Dividend Distribution - Since its A-share listing, Zhongyao Holdings has distributed a total of 864 million yuan in dividends, with 294 million yuan distributed over the last three years [3]. Institutional Holdings - As of September 30, 2025, Hong Kong Central Clearing Limited was the seventh largest circulating shareholder, holding 10.091 million shares, an increase of 851,000 shares from the previous period [3]. - The Southern CSI 1000 ETF was the ninth largest circulating shareholder, holding 7.898 million shares, which is a decrease of 55,600 shares compared to the previous period [3].
重药控股涨2.03%,成交额4720.33万元,主力资金净流入290.74万元